Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

This study presents an innovative approach to single-atom catalysts, overcoming oxidative addition challenges in cross-coupling reactions for pharmaceuticals.

“Skye believes nimacimab shows potential both as a monotherapy and in combination with a GLP-1 targeted drug to address unmet needs in obesity with the potential to change weight loss standards of ...

On Long Island, TCE has been found in contaminated groundwater and most recently in chemical-filled drums buried under a ...

Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click ...

A research team has successfully fine-tuned the Rabi oscillation of polaritons, quantum composite particles, by leveraging ...

A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor ...

In this installment of “LC Troubleshooting,” Dwight Stoll touches on highlights from Pittcon 2025 talks, as well as ...